Market Tracker

05/27 5:16pm ET

Mylan NV (NASDAQ:MYL)

43.06
Delayed Data
As of May 27
 +0.20 / +0.47%
Today’s Change
37.59
Today|||52-Week Range
74.66
-20.36%
Year-to-Date

Today’s Trading

Previous close42.86
Today’s open43.06
Day’s range42.89 - 43.84
Volume3,054,222
Average volume (3 months)5,747,057
Market cap$21.9B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.57%
Earnings growth (next 5 years)+11.41%
Revenue growth (last year)+21.91%
P/E ratio18.6
Price/Sales2.84
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+1.19+1.33%
ZTSZoetis Inc-0.15-0.32%
INCYIncyte Corp+2.75+3.36%
BMRNBiomarin Pharmaceuti...+1.83+2.10%
Data as of 4:04pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$1.14
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts